Vladislav Ovchinsky announced the entry of the capital company for the production of veterinary drugs to the Turkish market
[ad_1]
The company, located on the territory of the SEZ “Technopolis Moscow”, received a certificate according to the GMP standard of the Republic of Turkey. The document confirms the quality of veterinary drugs produced at the enterprise. With an international certificate, the company can enter the Turkish market.
“In 2022, Vetbiokhim completed the construction of a new plant on the territory of the Technopolis Moscow SEZ, having invested 1.6 billion rubles in the creation of production. This ensured the creation of more than 100 new jobs,” said Vladislav Ovchinsky, head of the capital’s Investment and Industrial Policy Department.
Ovchinsky added that at the moment, the domestic market receives 36 vaccines from the enterprise for farm and domestic animals, 4 immunoglobulin and serum preparations, as well as 56 types of test systems for detecting various diseases. Last year alone, the company registered and launched the production of 4 new vaccines. In order to gain an advantage in the foreign market, the manufacturer has been certified according to Turkish GMP standards. Now the company plans to export up to 10 million doses of vaccines annually.
According to Gennady Degtev, General Director of the Technopolis Moscow SEZ, representatives of the Ministry of Agriculture and Forestry of the Republic of Turkey came for certification. The experts were amazed by the modern equipment, the qualifications of the staff and much more.
[ad_2]
Source link
